Commerzbank Aktiengesellschaft Dexcom Inc Transaction History

Commerzbank Aktiengesellschaft

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$110.31 - $140.45 $31,658 - $40,309	-287 Reduced 13.81%	1,791 $204,000
Q1 2024 May 10, 2024	BUY	$114.22 - $140.1 $52,883 - $64,866	463 Added 28.67%	2,078 $289,000
Q4 2023 Sep 30, 2024	SELL	$75.49 - $124.16 $13,286 - $21,852	-176 Reduced 9.83%	1,615 $201,000
Q4 2023 Feb 01, 2024	BUY	$75.49 - $124.16 $121,916 - $200,518	1,615 New	1,615 $201,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.